Scientific Workshop on Decentralized Clinical Trials in Hematology: Reshaping the Traditional Clinical Trial Paradigm With AI Strategies for 'Real World' Patient Representation
Program: Scientific Workshops
Session: Implementation of Decentralized Clinical Trials
Program: Scientific Workshops
Session: Implementation of Decentralized Clinical Trials
Friday, December 6, 2024, 3:04 PM-3:51 PM
Disclosures: Borate: BMS: Consultancy; Incyte: Consultancy; Takeda: Other: IDMC; Daiichi Sankyo: Consultancy; Rigel: Consultancy; Astellas: Consultancy; Vincerx Pharma: Membership on an entity's Board of Directors or advisory committees; Beigene: Membership on an entity's Board of Directors or advisory committees; Abbvie: Consultancy; Novartis: Consultancy; Sumitomo: Consultancy.
See more of: Implementation of Decentralized Clinical Trials
See more of: Scientific Workshop on Decentralized Clinical Trials in Hematology: Reshaping the Traditional Clinical Trial Paradigm With AI Strategies for 'Real World' Patient Representation
See more of: Scientific Workshops
See more of: Scientific Workshop on Decentralized Clinical Trials in Hematology: Reshaping the Traditional Clinical Trial Paradigm With AI Strategies for 'Real World' Patient Representation
See more of: Scientific Workshops
Previous Presentation
|
Next Presentation >>